Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.3 was added to the page, indicating an updated record version. Older topics including Melanoma and MedlinePlus Genetics, as well as the prior Revision: v3.6.2, were removed from the changelog metadata.SummaryDifference0.1%

- Check20 days agoChange DetectedMelanoma and MedlinePlus Genetics are now listed under related topics, and the site revision tag was updated from v3.6.0 to v3.6.2, reflecting a metadata update to the page.SummaryDifference0.1%

- Check34 days agoChange DetectedRecruitment status now indicates no participants are being recruited, which affects potential enrollees and the current relevance of the study page. New Help/Navigation sections have been added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was standardized, and the page revision note was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, signaling a new software release for the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's metadata tags were reduced by removing Melanoma and the related topics: MedlinePlus Genetics, altering the set of topics associated with the study.SummaryDifference0.1%

- Check63 days agoChange DetectedMelanoma was added as a topic/tag and 'related topics: MedlinePlus Genetics' was added, expanding the page's metadata and linking to genetic resources. The page's revision reference was updated from v3.5.3 to v3.5.4, reflecting a labeling/version update.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.